TOAD trial shows increased prostate cancer survival

Australian researchers have discovered that men with incurable prostate cancer, but without symptoms, who received immediate hormone treatment on the TOAD trial, had an increase in survival over those who delayed treatment – with 80% still alive after six years, compared to 65% of men for whom treatment was delayed until they showed further symptoms